Persistence of CD33 expression at relapse in CD33+ acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease

被引：15
|
作者：
Chevallier, Patrice [1 ]
Robillard, Nelly [1 ]
Ayari, Sameh [1 ]
Guillaume, Thierry [1 ]
Delaunay, Jacques [1 ]
Mechinaud, Francoise [1 ]
Avet-Loiseau, Herve [1 ]
Mohty, Mohamad [1 ]
Harousseau, Jean-Luc [1 ]
Garand, Richard [1 ]
机构：
[1] Ctr Hosp Univ, Dept Haematol, Nantes, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 143卷 / 05期
关键词：
acute myeloid leukaemia; Gemtuzumab; Mylotarg; CD33; phenotype;
D O I：
10.1111/j.1365-2141.2008.07153.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：744 / 746
页数：3
相关论文
共 50 条
  • [21] CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients
    Lamba, Jatinder K.
    Voigt, Andrew P.
    Chauhan, Lata
    Shin, Miyoung
    Aplenc, Richard
    Brodersen, Lisa Eidenschink
    Gamis, Alan S.
    Meshinchi, Soheil
    Loken, Michael R.
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2250 - 2253
  • [22] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    Ehninger, A.
    Kramer, M.
    Roellig, C.
    Thiede, C.
    Bornhaeuser, M.
    von Bonin, M.
    Wermke, M.
    Feldmann, A.
    Bachmann, M.
    Ehninger, G.
    Oelschlaegel, U.
    BLOOD CANCER JOURNAL, 2014, 4 : e218 - e218
  • [23] Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
    Laszlo, George S.
    Harrington, Kimberly H.
    Gudgeon, Chelsea J.
    Beddoe, Mary E.
    Fitzgibbon, Matthew P.
    Ries, Rhonda E.
    Lamba, Jatinder K.
    McIntosh, Martin W.
    Meshinchi, Soheil
    Walter, Roland B.
    ONCOTARGET, 2016, 7 (28) : 43281 - 43294
  • [24] CD33 signaling in acute myeloid leukemia cells is dependent on SYK expression.
    Balaian, L
    Ball, ED
    BLOOD, 2001, 98 (11) : 573A - 573A
  • [25] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Stanchina, Michele
    Pastore, Alessandro
    Devlin, Sean
    Famulare, Christopher
    Stein, Eytan
    Taylor, Justin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [26] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Michele Stanchina
    Alessandro Pastore
    Sean Devlin
    Christopher Famulare
    Eytan Stein
    Justin Taylor
    Journal of Hematology & Oncology, 12
  • [27] The past and future of CD33 as therapeutic target in acute myeloid leukemia
    Laszlo, George S.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD REVIEWS, 2014, 28 (04) : 143 - 153
  • [28] Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
    Romao, Ema
    Krasniqi, Ahmet
    Maes, Laila
    Vandenbrande, Camille
    Sterckx, Yann G. -J.
    Stijlemans, Benoit
    Vincke, Cecile
    Devoogdt, Nick
    Muyldermans, Serge
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [29] Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells
    Vitale, C
    Romagnani, C
    Puccetti, A
    Olive, D
    Costello, R
    Chiossone, L
    Pitto, A
    Bacigalupo, A
    Moretta, L
    Mingari, MC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) : 5764 - 5769
  • [30] Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33 Positive Acute Myeloid Leukemia: Results from a French Retrospective Observational Study
    Lambert, Juliette
    Raffoux, Emmanuel
    Lebon, Delphine
    Braun, Thorsten
    Heiblig, Mael
    Santagostino, Alberto
    Gogat-Marchant, Karin
    Pautas, Cecile
    BLOOD, 2023, 142
12345